Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling.
- 2024-05-03
- Observational · n = 98
- Microorganisms 12(5)
- Angelica Nobili
- Marco Pane
- Mariya Skvortsova
- Meryam Ben Salem
- Stephan Morgenthaler
- Emily Jamieson
- Marina Di Stefano
- Eirini Bathrellou
- Eirini Mamalaki
- Victoria Ramos-Garcia
- Julia Kuligowski
- Miltiadis Vasileiadis
- Panagiotis Georgiadis
- Marika Falcone
- Paulo Refinetti
- PubMed: 38792760
- DOI: 10.3390/microorganisms12050931
- Moderate evidence
"In individuals with T1D, alterations were found at the metabolic level, with an overall increase in the level of the most measured metabolites"
- Effect
- Neutral
- Effect size
- Moderate